nSpire Health (clinical trials division) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

nSpire Health (clinical trials division) General Information

Description

Operator of clinical trials division. The unit is the clinical trials division for respiratory and inhaled therapeutics programs for asthma, COPD, cystic fibrosis and other indications.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Longmont, CO
  • United States
Primary Industry
Other Healthcare Services
Acquirer
Corporate Office
  • Longmont, CO
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

nSpire Health (clinical trials division) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore nSpire Health (clinical trials division)‘s full profile, request access.

Request a free trial

nSpire Health (clinical trials division) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore nSpire Health (clinical trials division)‘s full profile, request access.

Request a free trial

nSpire Health (clinical trials division) FAQs

  • Where is nSpire Health (clinical trials division) headquartered?

    nSpire Health (clinical trials division) is headquartered in Longmont, CO.

  • What industry is nSpire Health (clinical trials division) in?

    nSpire Health (clinical trials division)’s primary industry is Other Healthcare Services.

  • Is nSpire Health (clinical trials division) a private or public company?

    nSpire Health (clinical trials division) is a Private company.

  • What is nSpire Health (clinical trials division)’s current revenue?

    The current revenue for nSpire Health (clinical trials division) is .

  • Who are nSpire Health (clinical trials division)’s investors?

    nSpire Health has invested in nSpire Health (clinical trials division).

  • When was nSpire Health (clinical trials division) acquired?

    nSpire Health (clinical trials division) was acquired on 06-Aug-2015.

  • Who acquired nSpire Health (clinical trials division)?

    nSpire Health (clinical trials division) was acquired by iCardiac.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »